|
ZA989389B
(en)
*
|
1997-11-14 |
2000-04-14 |
Lilly Co Eli |
Pyrrolo [3,2-b] pyridine processes and intermediates.
|
|
US5905084A
(en)
*
|
1997-11-14 |
1999-05-18 |
Eli Lilly And Company |
5-HTIF -agonists effective in treating migraine
|
|
US6133290A
(en)
*
|
1998-07-31 |
2000-10-17 |
Eli Lilly And Company |
5-HT1F agonists
|
|
GB9823845D0
(en)
*
|
1998-11-02 |
1998-12-23 |
Lilly Co Eli |
Pharmaceutical compounds
|
|
AU1937300A
(en)
|
1998-12-11 |
2000-06-26 |
Eli Lilly And Company |
Indole derivatives and their use as 5-HT1F agonists
|
|
US7482366B2
(en)
|
2001-12-21 |
2009-01-27 |
X-Ceptor Therapeutics, Inc. |
Modulators of LXR
|
|
AU2002351412B2
(en)
|
2001-12-21 |
2010-05-20 |
Exelixis Patent Company Llc |
Modulators of LXR
|
|
TWI263497B
(en)
|
2002-03-29 |
2006-10-11 |
Lilly Co Eli |
Pyridinoylpiperidines as 5-HT1F agonists
|
|
ES2201899B1
(es)
*
|
2002-04-01 |
2005-06-01 |
Almirall Prodesfarma, S.A. |
Derivados de la azaindolilpiperidina como agentes antihistaminicos y antialergicos.
|
|
JP2006523692A
(ja)
|
2003-04-18 |
2006-10-19 |
イーライ リリー アンド カンパニー |
５−ｈｔ１ｆ作用薬としての（ピペリジニルオキシ）フェニル、（ピペリジニルオキシ）ピリジニル、（ピペリジニルスルファニル）フェニル、および（ピペリジニルスルファニル）ピリジニル化合物
|
|
UA82711C2
(en)
|
2003-09-12 |
2008-05-12 |
Эли Лилли Энд Компани |
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists
|
|
PH12012501891A1
(en)
*
|
2003-11-21 |
2013-09-02 |
Array Biopharma Inc |
Akt protein kinase inhibitors
|
|
DE602004008338T2
(de)
|
2003-12-17 |
2008-05-29 |
Eli Lilly And Co., Indianapolis |
Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten
|
|
ATE532789T1
(de)
|
2006-07-06 |
2011-11-15 |
Array Biopharma Inc |
Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
|
|
US8329701B2
(en)
|
2006-07-06 |
2012-12-11 |
Array Biopharma Inc. |
Dihydrofuro pyrimidines as AKT protein kinase inhibitors
|
|
NZ573979A
(en)
*
|
2006-07-06 |
2012-02-24 |
Array Biopharma Inc |
Cyclopenta [d] pyrimidines as akt protein kinase inhibitors
|
|
US8063050B2
(en)
*
|
2006-07-06 |
2011-11-22 |
Array Biopharma Inc. |
Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
MX2009014013A
(es)
*
|
2007-07-05 |
2010-01-28 |
Array Biopharma Inc |
Pirimidil ciclopentanos como inhibidores de la proteina cinasa akt.
|
|
US9409886B2
(en)
|
2007-07-05 |
2016-08-09 |
Array Biopharma Inc. |
Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
|
|
US8846683B2
(en)
|
2007-07-05 |
2014-09-30 |
Array Biopharma, Inc. |
Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
|
|
ES2551352T3
(es)
|
2007-07-05 |
2015-11-18 |
Array Biopharma, Inc. |
Pirimido ciclopentanos útiles para el tratamiento de enfermedades inflamatorias o hiperproliferativas
|
|
ES2422733T3
(es)
*
|
2008-01-09 |
2013-09-13 |
Array Biopharma Inc |
Pirimidilciclopentanos hidroxilados como inhibidores de proteínas cinasas AKT
|
|
EP2240455B1
(en)
*
|
2008-01-09 |
2012-12-26 |
Array Biopharma, Inc. |
Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
|
|
WO2010115125A2
(en)
|
2009-04-02 |
2010-10-07 |
Colucid Pharmaceuticals, Inc. |
Composition of 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide
|
|
WO2011123654A1
(en)
|
2010-04-02 |
2011-10-06 |
Colucid Pharmaceuticals, Inc. |
Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists
|
|
SG10201504303SA
(en)
|
2011-04-01 |
2015-07-30 |
Genentech Inc |
Combinations Of AKT Inhibitor Compounds And Chemotherapeutic Agents, And Methods Of Use
|
|
TR201815685T4
(tr)
|
2011-04-01 |
2018-11-21 |
Genentech Inc |
Kanser tedavisi için akt ve mek inhibe edici bileşiklerin kombinasyonları.
|
|
BG111544A
(bg)
*
|
2013-07-29 |
2015-01-30 |
Николай Цветков |
Субституирани бензамидни производни като in vitro mao-b инхибитори
|
|
AU2014298017B2
(en)
*
|
2013-08-02 |
2018-03-29 |
Pfizer Inc. |
Heterobicycloaryl RORC2 inhibitors and methods of use thereof
|
|
MA40759A
(fr)
*
|
2014-09-26 |
2017-08-01 |
Pfizer |
Modulateurs de rorc2 de type pyrrolopyridine substitué par un méthyle et trifluorométhyle et leurs procédés d'utilisation
|
|
MX376974B
(es)
*
|
2016-02-19 |
2025-03-07 |
Phoenix Molecular Designs |
Derivados de carboxamida útiles como inhibidores de rsk.
|
|
CA3107145A1
(en)
|
2018-08-24 |
2020-02-27 |
Sunshine Lake Pharma Co., Ltd. |
Pyridinylmethylenepiperidine derivatives and uses thereof
|
|
TWI826514B
(zh)
|
2018-09-04 |
2023-12-21 |
美商美國禮來大藥廠 |
用於預防偏頭痛之拉米迪坦(lasmiditan)長期夜間投藥
|
|
US12378245B2
(en)
|
2019-02-11 |
2025-08-05 |
Phoenix Molecular Designs |
Crystalline forms of an RSK inhibitor
|
|
TWI776175B
(zh)
|
2019-07-09 |
2022-09-01 |
美商美國禮來大藥廠 |
大規模製備2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺半琥珀酸鹽的方法及中間體，以及2,4,6-三氟-n-[6-(1-甲基-哌啶-4-羰基)-吡啶-2-基]-苯甲醯胺醋酸鹽之製備
|